Physician profile
Mohammad Riaz
NPI 1396770103
$562.28
in general payments reported to CMS, 2019-2025
16 companies · $13.57 in 2025
The $13.57 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $85.72 · 2021: $80.88 · 2022: $83.72 · 2023: $35.15 · 2024: $137 · 2025: $13.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $62.90 | 2022-2025 | Capvaxive, Pneumovax 23, Vaxneuvance |
| Phathom Pharmaceuticals, INC. | $55.76 | 2024 | Voquezna |
| Novo Nordisk INC | $54.82 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $52.70 | 2019-2020 | |
| Astellas Pharma US INC | $52.02 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $39.57 | 2019-2020 | |
| Amgen INC. | $34.62 | 2019 | |
| Glaxosmithkline, LLC. | $33.35 | 2020-2021 | |
| Lilly USA, LLC | $31.56 | 2021-2023 | Mounjaro |
| Averitas Pharma INC. | $30.00 | 2024 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $24.36 | 2022 | |
| Sanofi Pasteur INC. | $23.82 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.20 | 2021 | |
| Pfizer INC. | $17.63 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $13.85 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Riaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.